Multicellular organisms are composed of tissues that have distinct functions requiring specialized 7 proteomes. To define the proteome of a live animal with tissue and subcellular resolution, we 8 adapted a localized proteomics technology for use in the multicellular model organism 9
Introduction 22
Animal development and function relies on the coordinated expression of proteins in specific 23 tissues and the correct localization of those proteins to specific subcellular compartments. 24
Understanding both the tissue and the subcellular localization of a protein can be critical to 25 revealing its function. Because of the fundamental importance of understanding protein 26 localization, several experimental approaches have been established to globally define tissue-1 and compartment-specific protein expression. One approach relies on generating fluorescent 2 protein fusions with proteins of interest and analyzing protein localization using microscopy. A 3 seminal study using the single-celled yeast Saccharomyces cerevisiae determined the subcellular 4 localization of a majority of the proteome 1 . This fluorescent tagging approach has been 5 subsequently applied at the genome scale to the bacteria Escherichia coli and Caulobacter 6 crescentus 2-4 . Due to the cellular complexity in animals, global determination of protein 7 localization has been more challenging. Genome-wide fluorescent tagging approaches have been 8 initiated to analyze protein localization in the animals Caenorhabditis elegans and Drosophila 9 melanogaster. These efforts are impressive, but due to the large number of proteins and difficulty 10 in generating transgenic animals, the most comprehensive attempts so far have only localized 1-11 2 percent of the interrogated proteome. 5, 6 . 12
Another approach to define tissue and subcellular-specific proteomes relies on biochemical 13 isolation of tissues followed by mass-spectrometry to identify proteins. This approach has been 14 widely utilized to define large-scale tissue maps for the human and mouse proteomes based on 15 dissection of specific organs followed by mass spectrometry analysis 7, 8 , but these studies lack 16 cellular resolution within tissues, which can be comprised of multiple different cell types 9 . In 17 addition, these studies are difficult to perform with small organisms where tissue dissection is 18 challenging, such as with C. elegans. Cellular compartment-specific proteomes have also been 19 generated, but biochemical isolation techniques can result in a loss of integrity of isolated 20 subcellular compartments leading to incomplete or inaccurate spatial information 10 . 21
To address the drawbacks associated with tissue dissection, a class of approaches have been 22 developed to define protein expression in the individual tissues and cells of live animals. These 23 approaches rely on the tissue-specific expression of a modified tRNA synthetase that selectively 24 incorporates unnatural amino acids with chemical handles into the proteome. The labeled proteins 25 body wall muscle, and pharyngeal muscle). Subsequent isolation of biotinylated proteins and 1 identification by quantitative mass spectrometry allowed us to quantitatively compare proteins 2 detected in the cytoplasm and nucleus within each tissue to provide a catalog of protein 3 expression specific to either subcellular compartment within specific tissues. Together, these 4 results demonstrate a global approach to characterize tissue-and compartment-specific 5 proteomes in vivo. 6
Results 7

Development of spatially restricted enzymatic tagging in the intestine of C. elegans. 8
To develop a system for identifying proteins with a high degree of temporal, tissue, and subcellular 9 resolution in a live animal, we adapted the use of spatially restricted enzymatic tagging to the 10 nematode C. elegans, focusing first on the intestine (Fig. 1 ). We first generated transgenic 11 animals that express ascorbate peroxidase (APX) as a single genomic copy in C. elegans using 12 the MosSCI method 16 . The enzyme was fused to GFP for visualization, localized to the cytoplasm 13 using a nuclear export signal (NES), and specifically expressed in the intestine using the spp- 5 14 promoter. We confirmed the intestinal cytoplasmic-specific expression of this strain, GFP-APX-15 NES, by fluorescent microscopy (Fig. S1 ). As a negative control we also generated a strain in a 16 similar manner that expresses GFP in the intestine without the APX enzyme. 17
To test the activity of APX in C. elegans, we grew a single plate of 30,000 synchronized animals 18 on bacteria until the fourth larval (L4) stage (44 hours) at 20 °C. Populations of animals were 19 grown for both the strain expressing APX and the negative control strain expressing GFP without 20 APX. These animals were then washed off the plate and treated with the biotin-phenol substrate 21 for 1 hour, followed by the addition of H2O2 for 2 minutes. The labeling reaction was then quenched 22 and proteins from these animals were extracted and purified with streptavidin beads. Proteins 23 were then eluted from the beads, separated on SDS-PAGE gels, and visualized with Oriole 24 staining. In the absence of APX expression, endogenously biotinylated proteins were detected 17 . 1
The presence of APX did not result in the expected increase of biotinylated proteins compared to 2 the control GFP only expressing animals ( Fig. 2A) . 3
Based on a lack of APX-mediated biotin labeling and our observation that APX was properly 4 expressed, we hypothesized that the concentration of the biotin-phenol substrate in the worm 5
intestinal cells was inadequate to facilitate efficient protein labeling. To investigate whether 6 labeling efficiency could be improved by increasing the permeability of the C. elegans cuticle to 7 biotin-phenol, we knocked down the expression of the bus-8 gene. BUS-8 is a glycosyltransferase 8 involved in cuticle development, and reduction of BUS-8 function has been shown to increase 9 small molecule permeability by decreasing cuticle integrity 18 . Therefore, we fed animals bacteria 10 that express double-stranded RNA against bus-8 to induce RNAi knockdown of bus-8 expression. 11
Under these conditions, APX-expressing animals treated with the biotin-phenol substrate 12 displayed increased biotin tagging of proteins compared to control animals that do not express 13 APX ( Fig. 2A ). Therefore, decreasing cuticle integrity appears to increase availability of the 14 substrate, leading to increased biotinylation of cellular proteins by APX. Because of this 15 substantial increase in biotinylation efficiency, we performed all subsequent experiments by 16 growing animals on bacteria expressing the bus-8 RNAi clone to increase cuticle permeability and 17
APX-mediated protein biotinylation. 18
We then investigated whether the biotinylation reaction described above depends upon the 19 previously described components for an APX-mediated reaction: the APX enzyme, the biotin-20 phenol, and H2O2. First, we observed a slight increase in background biotinylation when the biotin-21 phenol was added to the control animals that do not express APX ( Fig. 2B ), indicating that a low 22 level of biotinylation occurs without the enzyme. However, there was a substantial increase in 23 labeling when animals expressing APX were exposed to biotin-phenol and H2O2 ( Fig. 2B) , 24 demonstrating that efficient biotinylation is greatly potentiated by APX expression. We also found 25 that both biotin-phenol and H2O2 were required for efficient labeling (Fig. 2B ), consistent with APX-1 mediated biotinylation in humans cells also being dependent on H2O2. Notably, in our experiments 2 animals are incubated with biotin-phenol for 1 hour, while H2O2 is only added for a period of 2 3 minutes before being quenched. Because H2O2 is required for labeling, this result indicates that 4 the labeling reaction is rapid and occurs within only 2 minutes in C. elegans. 5
Biotin labeling of proteins in specific locations within C. elegans. 6
To determine whether protein biotinylation and analysis could be performed in other tissues and 7 compartments in C. elegans, we created a panel of strains expressing the APX enzyme in different 8 tissues and subcellular locations. In addition to a version of the protein localized to the cytoplasm, 9
we created another version where APX is localized to the nucleus using a nuclear localization 10 signal (NLS). In addition to the intestine, we expressed the enzyme in three other tissues using 11 the following tissue-specific promoters: epidermis (dpy-7), body wall muscle (myo-3), and 12 pharyngeal muscle (myo-2) ( Table S1 ). In total, we generated eight strains expressing the APX 13 enzyme. This panel of strains and the negative control strain were grown and treated with biotin-14 phenol and H2O2 to label proteins as described above. The APX-mediated biotinylation of proteins 15 in each of these tissues was examined, revealing a clear increase in biotinylation in every location 16 compared to the negative control strain, with the exception of the nuclear localized enzyme in the 17 pharyngeal muscle ( Fig. 2C ). Of the tissues analyzed in our panel, this location represents the 18 smallest tissue and thus it is likely that labeled proteins could not be detected over background 19 biotinylation levels. 20
To confirm the location specificity of the labeling, we used fluorescence microscopy to visualize 21 where within the animal proteins were biotinylated. After treatment of the animals with biotin-22 phenol and H2O2, we fixed and stained the animals with anti-GFP antibodies to localize the fusion 23 protein and with fluorescent streptavidin to localize biotinylated proteins. Fluorescent microscopy 24 was used to analyze these stained animals and we found that the location of the biotin labeling 25 was dependent on the tissue and compartment where APX was expressed ( Fig. 3 ). Although 1 labeling could not be detected on gels when the enzyme was localized to the nucleus of the 2 pharyngeal muscle, efficient and specific labeling was observed in this location by microscopy 3 (Fig. 3 ). The control GFP only strain lacking APX did not display biotin labeling, demonstrating 4 the specificity of the approach (Fig. 3 ). The combined results from examining protein extracts and 5
from microscopy indicate the ability to label proteins in each of the eight locations that we tested. 6
Together this demonstrates the efficacy of in vivo spatially restricted enzymatic tagging in C. 7
elegans. 8
Identification of C. elegans cytoplasmic and nuclear proteins expressed in specific tissues 9 using mass spectrometry. 10
Having confirmed the tissue and cell compartment specificity of our in vivo APX-mediated 11 proximity tagging approach, we then set out to identify proteins that are present in the cytoplasm 12 and nucleus and in specific tissues using mass spectrometry. We employed a quantitative 13 strategy to rapidly and accurately compare proteins isolated from each tissue and between 14 different subcellular locations. To identify cytoplasmic and nuclear proteins, we used a set of three 15 strains for each tissue. We utilized the strains expressing APX-NES and APX-NLS in each tissue 16 and the negative control strain that expresses GFP without APX in the intestine. (Fig. 1 ). For the 17 three samples in each tissue set, proteins were labeled by APX-mediated biotinylation and 18 isolated as described above. Proteins bound to streptavidin-agarose from the three strains (GFP-19 APX-NES, GFP-APX-NLS, and GFP only) were then digested with trypsin. 20
For quantitative comparisons among the three samples in each tissue set, peptides from each 21 sample were labeled with a different isotopic tag using reductive dimethyl labeling ( Fig. 1) 19 . For 22 each tissue set, differentially-labeled reductive dimethylated peptides from each sample were 23 mixed in equal proportion prior to analysis by high-resolution mass spectrometry. Samples from 24 each tissue set were prepared and analyzed in triplicate. To evaluate the ability of this approach 25 to identify proteins above background levels, we initially performed control experiments using the 1 three strains of the intestine tissue set (GFP-APX-NES, GFP-APX-NLS, and GFP only). As a 2 control, we pooled peptide samples from each of the three strains, separated them into three 3 identical pools prior to dimethyl labeling, and upon remixing in equal amounts found that less than 4 5% of all proteins displayed quantitative ratios greater than 2-fold between pools establishing a 5 base false discovery rate for our experimental method ( Fig. S2A ). In contrast, when peptide 6 samples from the three strains were labeled by reductive dimethyl labeling individually before 7 mixing, over 90% of proteins from the APX-NES and APX-NLS samples had ratios over the GFP 8 only control sample greater than 2-fold ( Fig. S2B ). These control experiments demonstrate the 9 effectiveness of using reductive dimethyl labeling and mass spectrometry to quantitatively identify 10 APX-mediated biotinylated proteins and established a 2-fold threshold as being able to 11 differentiate proteins above background which we employed in subsequent analyses. 12
To identify proteins that are present in the eight locations we analyzed, ratios of proteins identified 13 from the APX-NES and APX-NLS strains for each tissue were compared to the GFP-only control 14 strain. We evaluated the reproducibility of our approach by comparing how many proteins with 15 ratios greater than 2-fold over background were identified in at least one replicate compared to 16 those identified in all three replicates ( Fig. S3 ). In the largest locations measured, the cytoplasm 17 of the intestine and epidermis, over 60% of proteins that were identified 2-fold above background 18 in one replicate were also identified as 2-fold above background in the two other replicates. In 19 contrast, in the smallest location measured, the pharyngeal nucleus, only 3% of proteins identified 20 2-fold above background in one replicate were also 2-fold above background in the two other 21
replicates. These differences are largely due to the variability in the number of proteins identified 22 between replicates. For example, the number of proteins identified in the intestinal cytoplasm 23
were between 2376 to 2575, while for the pharyngeal nucleus the range was much larger, with 24 between 116 to 759 proteins identified ( Fig. S3 ). 25
We then identified proteins from each of the experimental strains using the criteria that each 1 protein has a ratio at least 2-fold over background in 2 of the 3 biological replicate experiments 2 (see methods). Using these criteria, we identified between 108 to 2484 proteins for each of the 8 3 strains (Fig. 4A ). The proteins identified and ratios between pairs of strains in the same tissue set 4 are reported in Table S2 . The largest tissues, the intestine and epidermis, had the most identified 5 proteins, followed by the body wall muscle and then the pharyngeal muscle. More proteins were 6
identified from the cytoplasm than from the nucleus for each tissue. A total of 3187 proteins were 7
identified in at least one of the eight strains ( Fig 4B) . 8
Identification of tissue and subcellular specific C. elegans protein expression. 9
We then investigated which of the proteins that we identified displayed tissue-specific expression. 10
To identify proteins that are tissue-specific, we compared proteins that were detected as being 2-11 fold above background in one of the four tissues in two of the three replicates and not detected 12 2-fold above background in any of the replicates in the other three tissues. This resulted in the 13 identification of 338 proteins that were specific to only one tissue ( Fig. 4C ). To assess the 14 accuracy of these proteins identified as tissue-specific, we compared them to an existing 15 comprehensive data set of tissue-specific mRNA expression 20 . This data set was generated from 16 experimental expression data and prediction scores were made for each gene in each of the four 17 tissues we tested. The set of proteins we identified as being specific for each tissue had the 18 highest average mRNA expression scores in that tissue compared to the other three supporting 19 the accuracy of our technique, tissues ( Fig. 4D) . We identified the largest number of proteins from 20 the intestine and epidermis as being tissue-specific. These tissues also had the lowest mRNA 21 expression scores for the proteins identified as being specific to other tissues. We identified the 22 fewest proteins from the pharyngeal muscle as being tissue-specific and this tissue also had 23 higher mRNA expression scores for the proteins identified as being specific to other tissues. This 24 lowered accuracy is likely due to identifying fewer total proteins in the pharyngeal muscle 25 compared to the other tissues ( Fig. 4A ). Thus some proteins that we describe as specific to non-1 pharyngeal tissues may actually be expressed in the pharyngeal muscle as well, but we failed to 2 detect them in the pharyngeal muscle due to the lowered sensitivity for our technique in this small 3 tissue. This result suggests these analyses are more useful for the large tissues where we 4 identified more proteins. However, because the pharyngeal-specific proteins we describe do have 5 the highest expression score in the pharynx in comparison to the other tissues, it demonstrates 6 that this analysis is still useful for identifying tissue-specific proteins even in smaller tissues. 7
We then examined the subcellular specificity of the proteins we identified by comparing the ratios 8 of protein levels in the nucleus compared to protein levels in the cytoplasm. We used the 9 quantitative ratios between the APX-NES and APX-NLS samples to find proteins that were 2-fold 10 enriched in either sample (Fig. S4 ). This comparison resulted in the identification of 1087 proteins 11 specific to the cytoplasm and 428 proteins specific to the nucleus (Fig. 4E) . To assess the 12 accuracy of these location assignments we performed GO term enrichment analysis using 13 PANTHER 21 . Here we found that proteins we identified as being cytoplasm-or nucleus-specific 14
were highly enriched for proteins previously annotated to be cytoplasmic or nuclear ( Fig. 4E ). Of 15 the 428 proteins identified as nucleus-specific, 176 were not previously known to be nuclear 16 localized (Fig. 4F ). We also examined the compartment specificity of the proteins we classified 17 as being tissue-specific and identified 115 of these proteins as being cytoplasm-specific and 12 18 as being nucleus-specific ( Fig. 4C) . 19
To validate our results, we used fluorescence microscopy to confirm the localization of several 20 proteins that we identified to be expressed in specific tissues or subcellular locations using our 21 quantitative proteomics approach. We chose 7 proteins that we measured with high confidence 22
to be either nucleus-specific, cytoplasm-specific, or specific to one of the four tissues (Fig. S5) . 23
These seven proteins had no previous experimentally determined location described in 24 WormBase (http://www.wormbase.org). Using TransgeneOme 5 constructs that contain C-25
terminal GFP fusions of each protein expressed under the native promoter, we generated strains 1 of transgenic animals overexpressing each protein. We found that each of these seven test 2 proteins localized to the corresponding tissue or subcellular location that we identified by spatially 3 restricted enzymatic tagging (Fig. 5) . These results confirm the accuracy of our approach, and 4 demonstrate the efficacy of using in vivo proximity-based labeling methods and quantitative mass 5 spectrometry to identify proteins with tissue-specific and/or subcellular compartment-specific 6
localization. Overall, we present a robust method that can be applied to detect in vivo protein 7 localization in an unbiased manner within intact animals and provide a resource of proteins with 8 specific locations in C. elegans (Table S2) . 9
Discussion 10
Here, we describe an approach that allows for the determination of in vivo protein localization in 11 an intact animal through the use of spatially restriced enzamatic tagging. To our knowledge this 12 is the first in vivo localization of a large number of proteins with subcellular resolution in a live 13 animal. Using spatially restricted enzymatic tagging in C. elegans, we provide one of the largest 14 systematic identifications of proteins that have tissue or compartment-specific localizations. We 15 identified a total of 3187 proteins, of which 1673 are localized to a specific tissue or subcellular 16 compartment. This resource represents an advancement from previous studies aimed at 17 identifying protein localization using GFP-tagging, in which the location of 230 proteins were 18 characterized. A different approach using unnatural amino acid labeling in the pharyngeal muscle 19 in C. elegans identified 43 proteins that were greater than 2-fold enriched above background 20 levels 11 . In contrast our technique identified 887 proteins total in either the cytoplasm or nucleus 21 of the pharyngeal muscle. 22
Despite our success in using spatially restricted enzymatic tagging to identify tissue and 23 subcellular specific protein expression, there are some limitations to this approach that warrant 24 discussion. The number of proteins identifed even in the largest tissues is only ~25% of the 25 number of mRNAs demonstrated to be expressed in the same tissue 22 . Additionally, fewer 1 proteins were identified in the smaller tissues than larger tissues, and in the nucleus compared to 2 the cytoplasm. These concerns may be addressed in the future by using recently developed 3 versions of APX that have increased sensitivity 23 . Additionally, as the variability of identified 4 proteins in the smaller tissues was greater (Fig. S3 ), the measurement of additional replicates 5 could be used to increase sensitivity of protein detection. Another issue is that our approach relies 6 on feeding animals bus-8 RNAi, which causes improper development of the cuticle and 7 locomotion defects 18 . However, we were able to confirm the specific location of a number of 8 proteins using transgenic analysis in wild-type animals, demonstrating that protein localization in 9 bus-8-defective animals appears to be largely similar to wild-type animals. Additonally, there are 10 potentially other mutants or chemical approaches that could be employed to improve the 11 accessibility of the biotin-phenol substrate and may lessen their physiological impact on the 12
animals. 13
The methodology we describe here can be expanded upon to obtain greater tissue and 14 subcellular resolution. Spatially restricted enzymatic tagging has also been reported to work in 15 other subcellular locations in human cells including the endoplasmic reticulum, mitochondria, and 16 plasma membrane 13 . We were able to identify proteins from all eight of the locations to which we 17 localized the enzyme. Thus, it is likely that this approach could be applied to a number of other 18 tissues and subcellular locations in C. elegans. 19
This technique we describe also could be useful for a number of applications. This technique 20 could be used to determine protein translocation between the cytoplasm and the nucleus in 21 different growth conditions. Through the use of a yeast GFP-tagged library, 71 cytoplasmic 22 proteins were shown to localize to the nucleus under starvation conditions, demonstrating that 23 large numbers of proteins translocate in response to stress 24 . Using our described approach, 24 these types of translocation events could be measured globally in live animal using a smaller 25 number of strains, to investigate the response to various stress conditions. Although our 1 experiments were focused on quantifying differences between the cytoplasm and nucleus, the 2 quantitative labeling scheme we employed is flexible and could be used to directly compare levels 3 of proteins between different tissues. Additionally, this approach could also be adapted to 4 measure posttranslational modifications, such as phosphorylation. This would allow comparing 5 differences in post-translational modifications of proteins between different compartments and 6 between different tissues 25 . This approach can also be applied to identify proteins from pathogenic 7 or symbiotic microbes that localize to different host tissues and subcellular locations 26 . Spatially 8 restricted enzymatic tagging has now been reported in D. melanogaster, C. elegans, and human 9 cells and thus can likely be used in any organism where transgenic techniques exist and biotin-10 phenol can be delivered. 11
12
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biotin-phenol that diffuses into cells. The APX enzyme, in presence of H2O2 and biotin-phenol 7
catalyzes the formation of a phenoxyl radical that covalently labels neighboring proteins with biotin 8
(red B with black bars) 13 . Thus, biotin labeling (labeled in red) of proteins occurs in whichever 9 specific tissues and subcellular locations the enzyme is expressed. Three strains are used to 10 measure protein localization in each tissue: GFP only, GFP-APX-NES, and GFP-APX-NLS. 11
Spatially restricted tagging is performed using these three strains and then the proteins are 12 extracted and purified using streptavidin beads. These purified proteins are then digested into 13 peptides and labeled using reductive dimethyl labeling for quantitative comparisons between the 14 three strains. The peptides from each sample are then combined and peptide ratios in each 15 sample are measured using mass spectrometry. The peptide ratios can then be used to determine 16
if the protein is detected over background and if it is enriched in either the nucleus or cytoplasm. Spatially restricted enzymatic tagging was performed on strains of C. elegans expressing APX in 3
the cytoplasm or nucleus of the intestine, epidermis, body wall muscle, or pharyngeal muscle as 4 indicated. A strain expressing GFP without APX was used as a negative control. Animals were 5
fixed and stained for GFP (top, green) to determine the localization of the enzyme, and 6 streptavidin (middle, red) to determine the location of protein biotinylation. Representative images 7
are shown for each strain. Animals are aligned so that the anterior is up. Tissue expression 8 diagrams show the location of each tissue in C. elegans (Bottom). identified in our experiments that were detected in different locations or that were detected as 6
being specific to a location. c. The number of proteins we identified in the indicated tissue, but not 7
in the other three tissues. For each tissue, three categories of proteins are shown, those that are 8 specific to the cytoplasm (orange), those that are specific to the nucleus (blue), and those that 9
are not specific to either compartment (grey). d. Comparison of the identified tissue-specific 10 proteins to a dataset of predicted mRNA expression 20 . The data presented are the average of all 11 the mRNA expression prediction scores for each tissue-specific protein in each of the four tissues. 12
Higher prediction scores are more likely to be expressed in that tissue. Each column represents 13 proteins identified as specific to that tissue, compared to the predicted mRNA expression of the 14 tissue in each row. The highest average score in each column is shaded in green, and all other 15 scores in the column are shaded in red. e. GO term enrichment analysis of proteins identified in 1 our experiments as specific to either the cytoplasm or the nucleus. f. Pie chart of the nucleus-2 specific proteins we identified in our experiment, and whether they have a GO term location of 3 either the nucleus, cytoplasm, both, or neither. Strains of transgenic C. elegans expressing GFP-tagged proteins identified to be tissue-specific 3 or location-specific in our study. Animals were grown to the L4 stage and representative images 4 displaying protein localization are shown. The protein name is listed above each construct-5 expressing strain. The tissue and subcellular localization determined from our proteomic data is 6
listed below the protein name. Animals are aligned so that the anterior is up. 7 8
Methods 1
Cloning and generation of strains 2
The protein sequence of soybean ascorbate peroxidase (APX) with the W41F mutation 13 was 3 optimized for C. elegans expression using DNAworks to design primers 27 . Primers were annealed 4 using a two-step PCR method and double-stranded DNA was cloned into Gateway vector pDONR 5 221 using BPclonase II (Thermo Fisher). This construct was modified using Gibson cloning 28 with 6 an N-terminal fusion of GFP. This construct was additionally modified to encode the C-terminal 7 nuclear export signal (NES: LQLPPLERLTLD) and nuclear localization signal (NLS: 8 PKKKRKVDPKKKRKVDPKKKRKV) by encoding these tags into primers, amplifying the plasmid 9 with PCR and ligating the PCR product. Upstream regions of the following C. elegans genes were 10 used as promoters: dpy-7 (epidermis) spp-5 (intestine) myo-2 (pharyngeal muscle) myo-3 (body 11 wall muscle). These promoters were cloned into the 5' plasmid pDONR P4-P1R using BP clonase 12 II (Thermo Fisher). Multisite Gateway cloning was used to generate targeting constructs using LR 13 clonase II plus (Thermo Fisher) to combine one of the four promoter plasmids, one of the two 14 APX containing plasmids, the 3' plasmid pDONR P2R-P3 vector containing the 3' region of unc-15 54, and the destination vector pCFJ150. These targeting constructs along with the Mos1 16 transposase and marker plasmids were injected into unc-119 mutants from the strain EG6699 29 . 17
Non-Unc worms were recovered and each transgenic strain was backcrossed into the wild-type 18 N2 strain 3 times. The homozygote was used in subsequent experiments. Transgenic strains 19 expressing transgeneOme GFP-tagged proteins as extrachromosomal arrays were generated by 20 injection of constructs into EG6699 and selecting non-unc animals. The following amount of DNA 21 was injected for each construct: 100 ng/µl of each construct for F33C8.4, Y45F10B.13, F59D12.2, 22 and F29C6.1, 50 ng/µl of the construct with 50 ng/µl pBSK for F42A10.5, and 10 ng/µl of the 23 construct with 90 ng/µl pBSK for W05H9.1 and K01G5.5. All strains used in the study are listed 24
in Table S1 . All C. elegans strains were maintained using standard procedures 30 . 25
26
Spatially restricted enzymatic tagging in C. elegans 1
Populations of animals were grown and bleached to recover eggs, which were then hatched to 2 generate first larval stage (L1) synchronized animals 30 . ~30,000 L1 animals of each strain in 2.5 3 ml M9 buffer were added to a 15 cm RNAi plate seeded with HT115 bacteria expressing a bus-8 4
RNAi feeding clone 31 . Animals were protected from light and grown to the L4 stage on these plates 5 for 44 hours at 20°C. To recover animals, each plate was washed with M9T (M9/0.1% Tween-6 20). The recovered animals were washed once with M9T. These animals were then placed into 7 1.5 ml tubes in a total of 100 µl M9T. To each sample was added 900 µl of labeling solution (0.1% 8 Tween-20, M9, and 3.3 mM biotin-phenol, synthesized as previously described) 13 . Samples were 9 incubated for 1 hour at 22-24°C on an end-over-end rotator. To activate biotin labeling, 10 µl of 10 100 mM H2O2 was added for 2 minutes. To quench the reaction, 500 µl quench buffer (M9/0.1% 11 TWEEN-20/ 10 mM sodium azide/ 10 mM sodium ascorbate/ 5mM Trolox) was added. Samples 12 were then washed with 1 ml of quench buffer 4 times. After the last wash, the remaining buffer 13 was removed and 800 µl lysis buffer (150 mM NaCl/ 50 mM Tris pH 8.0/1% TritonX-100/0.5% 14 sodium deoxycholate/0.1%SDS/10 mM sodium azide/ protease complete tablet (Roche)/ 10 mM 15 sodium ascorbate/ 5mM Trolox/1 mM PMSF) was added. Animals were then immediately frozen 16 dropwise in liquid N2. 17
18
To extract proteins, frozen worm pellets were ground to a fine powder in liquid N2. To generate 19 supernatants these protein extracts were then centrifuged for 10 min at 21,000 × g at 4 °C. The 20 supernatant was then filtered over a desalting column with a 7 kilodalton molecular weight cutoff 21 (Pierce). The protein concentrations of the extracts were measured using a Pierce 660 nm Protein 22
Assay and normalized. To 450-550 µg of each sample was added 25 µl of high capacity 23 streptavidin agarose resin (Pierce) in a total of 700 µl lysis buffer. Extracts were incubated with 24 beads for 1 hour on an end-over end rotator. Beads were then washed 5 times with 1 ml lysis 25 buffer, 3 times with 1 ml 8M urea/10 mM Tris pH 8.0, and 3 times with 1 ml PBS. The liquid was 26 removed from the beads and 100 µl of 0.1 µg/µl trypsin (Promega)/100 mM TEAB was added to 1 each sample and incubated at 37°C for 24 hours. 2 3 These peptides were then differentially labeled with reductive dimethyl labeling as previously 4 described 19 . Briefly, each of the three samples in the set was labeled with a different isotopic tag 5 that differed by four daltons. To generate samples with a light tag, 4 µl of 4% (v/v) CH2O and 4 µl 6
600mM NaBH3CN was added. The other tags were generated in a similar way, with CD2O and 7
NaBH3CN being used for the medium tag and C 13 D2O and NaBD3CN being used for the heavy 8 tag. Samples were then incubated for one hour with mixing on an end-over-end rotator. To quench 9 the reaction, 16 µl of 1% (v/v) ammonia was added to each sample. The samples were then 10 acidified by adding 8 µl of formic acid. The three samples in each set were then combined. 11 12 Gel analysis of biotinylated proteins 13 From samples prepared as described above, 15% of beads were removed before digestion. To analyze biotin labeling with immunohistochemistry, worms were fixed using Bouin's tube 21 fixation method 32 . Fixed worms were stained overnight with 1:500 anti-GFP mouse antibody 22 (Roche) in block buffer (phosphate buffered saline/0.5% TritonX-100, 1% Bovine serum albumin). 23
Worms were then washed with block buffer and stained overnight with 1:500 FITC-conjugated 24 anti-mouse secondary antibody (Invitrogen) and 1:500 streptavidin Alexa Fluor 568 (Thermo 25
Fisher) in block buffer. Worms were then washed in block buffer and imaged using a Zeiss 26 LSM700 confocal microscope. Live worms expressing GFP-tagged TransgeneOme constructs 5 1 were grown to the L4 stage, treated with 1 mM levamisole and then imaged as described above. 
Sample analysis by mass spectrometry 4
Prior to analysis by LC-MS/MS, peptides were desalted by solid-phase extraction using in-house 5 prepared C18 StageTips 33 and reconstituted in 5% formic acid and 5% acetonitrile (ACN). All 6 samples were analyzed in triplicate using a Q Exactive mass spectrometer (Thermo Scientific, 7
San Jose, CA). The following is a generalized nHPLC and data acquisition method that is 8 representative of individual analyses. Peptides were first separated by reverse-phase 9 chromatography using a fused silica microcapillary column (75 μm ID, 18 cm) packed with C18 10 silica (ReproSil-Pur 120 C18-AQ, 1.9 µm, Dr. Maisch GmbH) using an in-line nano-flow EASY-11 nLC 1000 UHPLC system (Thermo Scientific). Peptides were eluted over a 100 minute 0-30% 12 ACN gradient, followed by a 5 minute 30-60% ACN gradient, a 5 minute 60-95% ACN gradient, 13 with a final 10 minute isocratic step at 0% ACN for a total run time of 120 minutes at a flow rate 14 of 250 nl/min. All gradient mobile phases contained 0.1% formic acid. MS/MS data were collected 15 in data-dependent mode using a top 10 method with a full MS mass range from 400-1800 m/z, 16 70,000 resolution, and an AGC target of 3e6. MS2 scans were triggered when an ion intensity 17 threshold of 1e5 was reached with a maximum injection time of 60 ms. Peptides were fragmented 18 using a normalized collision energy setting of 25. A dynamic exclusion time of 20 seconds was 19 used and the peptide match setting was disabled. Singly charged ions, charge states above 6 20 and unassigned charge states were excluded. 21 22
Peptide and protein identification and quantification 23
The resultant RAW files were converted into mzXML format using the ReAdW.exe (version 4.3.1) 24
program. The SEQUEST search algorithm (version 28) was used to search MS/MS spectra 25 against a concatenated target-decoy database comprised of forward and reversed sequences 26 from the reviewed UniprotKB/Swiss-Prot FASTA C. elegans database combined with the 1 UniprotKB E. coli (K12 strain) database, and with common contaminant proteins appended. Each 2 mzXML file was searched in triplicate with the following parameters: 20 ppm precursor ion 3 tolerance and 0.01 Da fragment ion tolerance; Trypsin (1 1 KR P) was set as the enzyme; up to 4 three missed cleavages were allowed; dynamic modification of 15.99491 Da on methionine 5 (oxidation). For searches with light and medium reductive dimethyl labels, additional dynamic 6 modifications of 4.0224 Da on lysine and peptide N-termini and static modifications of 28.0313 7
Da on lysine and peptide N-termini were included. For searches with light and heavy reductive 8 dimethyl labels, additional dynamic modifications of 8.04437 Da on lysine and peptide N-termini 9 and static modifications of 28.0313 Da on lysine and peptide N-termini were included. For 10 searches with medium and heavy reductive dimethyl labels, additional dynamic modifications of 11 4.02193 Da on lysine and peptide N-termini and static modifications of 32.05374 Da on lysine and 12 peptide N-termini were included. Peptide matches were filtered to a peptide false discovery rate 13 of 2% using the linear discriminant analysis. Proteins were further filtered to a false discovery rate 14 of 2% and peptides were assembled into proteins using maximum parsimony and only unique 15 and razor peptides were retained for subsequent analysis. All peptide Heavy:Light, Medium:Light, 16
and Heavy:Medium ratios with a signal to noise ratio above 5 were used for assembled protein 17 quantitative ratios. 18
19
Analysis of mass spectrometry data 20
We classified a protein as being identified above background if it had a greater than 2-fold ratio 21 of NLS or NES over the GFP only strain in 2/3 replicates for a given tissue. The requirements for 22 a protein being classified as being tissue-specific were 1) having a greater than 2-fold ratio of 23 NLS/GFP in 2/3 replicates or a greater than 2-fold ratio of NES/GFP in 2/3 replicates in one of the 24 tissues and 2) not detected in any of the other tissues with greater than a 2-fold ratio of NLS/GFP 25
